Latest News

Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017

Feb. 7, 2018

Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017.

Kamada Announces Interim Results from Phase 2 Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection

Jan. 8, 2018

The company announced interim results from the Company’s Phase 2 trial of intravenous Alpha-1 Antitrypsin (IV AAT) for the prevention of lung transplant rejection.

Upcoming Events

Kamada to participate in the 7th Northern European Conference on Travel Medicine (NECTM7)

May. 2-4, 2018 / Stockholm, Sweden

The NECTM7 conference will reflect the multi-disciplinary nature of travel health from the basic knowledge to the latest research and including both nurses, clinicians, academics and students.

Kamada to participate in ATS 2018 conference

May. 18-23, 2018 / San Diego, CA, USA

The congress is expected to attract over 17,000 clinical investigators, scientists and medical professionals related to the fields of sleep medicine pulmonary, and critical care. Aimed at displaying and delivering the educational sessions about recent advancements in research related to Pneumology the conference will show-up as a benchmark and turning point for the medical personnel.

Past Event

Kamada to participate in H. C. Wainwright Global Biotechnology Conference

Apr. 8-10, 2018 / Monte Carlo, Monaco

H.C. Wainwright & Co. is one of the country’s oldest and leading financial institutions. Their  services are tailored to meet the clients’ needs and their expertise spans a wide range of industries and organizations. They are devoted to building long-term relationships with clients and find that many of the clients seek their services on a repeated basis.